Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Manifold Bio is a platform-based biotechnology company focused on the design and development of tissue-targeted protein therapeutics. The company utilizes its proprietary "direct-to-vivo" discovery engine, which leverages "mCodes" (protein barcodes) to track and quantify thousands of drug candidates simultaneously in living systems. This high-throughput approach allows for the identification of biologics with superior delivery and specificity, particularly for challenging targets like the blood-brain barrier. Manifold Bio aims to overcome the translational gap between in vitro assays and human clinical outcomes by generating physiologically relevant data early in the discovery process.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Manifold Robotics.